The Chemours Company (VIE:CHEM)

The Chemours Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	5,808	5,782	6,078	6,831	6,345
Revenue Growth (YoY)	0.45%	-4.87%	-11.02%	7.66%	27.69%
Cost of Revenue	4,906	4,640	4,776	5,215	4,964
Gross Profit	902	1,142	1,302	1,616	1,381
Selling, General & Admin	799	598	1,286	710	592
Research & Development	108	109	108	118	107
Other Operating Expenses	59	116	153	16	6
Operating Income	-64	319	-245	772	676
Interest Income	35	43	45	55	43
Interest Expense	-269	-263	-208	-163	-185
Other Non-Operating Income (Expense)	21	7	90	77	142
Total Non-Operating Income (Expense)	-213	-213	-73	-31	-
Pretax Income	-277	106	-318	741	676
Provision for Income Taxes	109	37	-66	163	68
Net Income	-386	69	-253	578	608
Minority Interest in Earnings	-	-	1	-	-
Net Income to Common	-386	69	-253	578	608
Net Income Growth	-	-	-	-4.93%	177.63%
Shares Outstanding (Basic)	150	149	149	155	165
Shares Outstanding (Diluted)	150	150	149	158	169
Shares Change (YoY)	0.04%	0.85%	-5.93%	-6.27%	1.53%
EPS (Basic)	-2.57	0.46	-1.70	3.72	3.69
EPS (Diluted)	-2.57	0.46	-1.70	3.65	3.60
EPS Growth	-	-	-	1.39%	172.73%
Free Cash Flow	51	-993	186	448	537
Free Cash Flow Growth	-	-	-58.48%	-16.57%	-0.56%
Free Cash Flow Per Share	0.34	-6.61	1.25	2.83	-
Dividends Per Share	0.512	1.000	1.000	1.000	1.000
Dividend Growth	-48.75%	-	-	-	-
Gross Margin	15.53%	19.75%	21.42%	23.66%	21.77%
Operating Margin	-1.10%	5.52%	-4.03%	11.30%	10.65%
Profit Margin	-6.65%	1.19%	-4.15%	8.46%	9.58%
FCF Margin	0.88%	-17.17%	3.06%	6.56%	8.46%
EBITDA	276	628	47	1,063	993
EBITDA Margin	4.75%	10.86%	0.77%	15.56%	15.65%
EBIT	-64	319	-245	772	676
EBIT Margin	-1.10%	5.52%	-4.03%	11.30%	10.65%
Effective Tax Rate	-39.35%	34.91%	20.75%	22.00%	10.06%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.